About Xaipe

---

Xaipe Capital is a hybrid investment firm that combines long-short public equity, venture capital and private equity strategies to invest across high-growth sectors, with a primary focus on biotechnology and technology. The firm employs a fundamental, sub-sector equity strategy supplemented by a targeted event-driven M&A approach, seeking to generate outsized returns by identifying compelling opportunities across both public and private markets.

A core component of Xaipe Capital’s strategy involves investing in companies with a high probability of fundamental value creation as well as seeking opportunities to invest in companies that are likely to generate strong strategic interest. Drawing on decades of direct experience as senior investment bankers advising on nearly $200 billion of complex mergers & acquisitions and raising $65 billion in capital, serving in the C-suite at public and private growth-stage companies, and serving on the board of directors of multiple public and private companies, the team brings a proprietary lens to sourcing and investing in unique and compelling opportunities.

The Xaipe Capital team leverages deep capital formation and strategic advisory experience from investment banking leadership roles at Morgan Stanley, Credit Suisse and BofA Merrill Lynch. This M&A and capital markets experience is complemented by strategic, operational and corporate governance insights gained from experience serving both in the C-suite and on the board of directors for multiple public and private companies, including a high level of involvement during critical M&A transactions for those companies ranging from $100 million to over $3 billion. This blend of strategic, capital markets and operational expertise enables Xaipe Capital to be a true value-added partner to portfolio companies across all stages of growth.

With a flexible investment mandate and a deep sector focus, Xaipe Capital is positioned at the intersection of institutional sophistication and entrepreneurial agility—committed to uncovering differentiated opportunities and building enduring value for investors and portfolio companies alike.